Your browser doesn't support javascript.
loading
Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics.
Liu, Zhenghong; Ma, Xiaoxuan; Ilyas, Iqra; Zheng, Xueying; Luo, Sihui; Little, Peter J; Kamato, Danielle; Sahebkar, Amirhossein; Wu, Weiming; Weng, Jianping; Xu, Suowen.
Affiliation
  • Liu Z; Department of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
  • Ma X; Department of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
  • Ilyas I; Department of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
  • Zheng X; Department of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
  • Luo S; Department of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
  • Little PJ; Sunshine Coast Health Institute, University of the Sunshine Coast, Birtinya, QLD 4575, Australia.
  • Kamato D; School of Pharmacy, Pharmacy Australia Centre of Excellence, the University of Queensland, Woolloongabba, Queensland 4102, Australia.
  • Sahebkar A; School of Pharmacy, Pharmacy Australia Centre of Excellence, the University of Queensland, Woolloongabba, Queensland 4102, Australia.
  • Wu W; Halal Research Center of IRI, FDA, Tehran, Iran.
  • Weng J; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad. Iran.
  • Xu S; Changshu Hospital Affiliated to Nanjing University of Chinese Medicine, Changshu, China.
Theranostics ; 11(9): 4502-4515, 2021.
Article in En | MEDLINE | ID: mdl-33754074

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Atherosclerosis / Sodium-Glucose Transporter 2 / Sodium-Glucose Transporter 2 Inhibitors Limits: Animals / Humans Language: En Journal: Theranostics Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Atherosclerosis / Sodium-Glucose Transporter 2 / Sodium-Glucose Transporter 2 Inhibitors Limits: Animals / Humans Language: En Journal: Theranostics Year: 2021 Document type: Article Affiliation country: